We are live on ! Find out more
CPHI icon

China Pharma Holdings

8 hedge funds and large institutions have $420K invested in China Pharma Holdings in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding

Funds holding: 88 (0)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

52% less capital invested

Capital invested by funds: $884K → $420K (-$464K)

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

CPHI Hedge Fund Activity: Q4 2015 in Review

8 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2015, worth a combined $420K — down 52% from $884K a quarter earlier.

Fund positioning in CPHI was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.1K. The largest seller was First Wilshire Securities Management, cutting an estimated $40.7K.

  • 8 institutional investors held China Pharma Holdings (CPHI) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $420K of China Pharma Holdings stock for Q4 2015, down 52% quarter-over-quarter.
  • 0 funds opened new China Pharma Holdings positions in Q4 2015 and 0 closed out.
  • The largest China Pharma Holdings buyer in Q4 2015 was Citadel Advisors, an estimated $3.1K added.
  • The largest China Pharma Holdings seller in Q4 2015 was First Wilshire Securities Management, an estimated $40.7K sold.

Based on aggregated 13F filings for Q4 2015.